Oncology

Antineoplastic and supportive medicines frequently subject to allocation, regional shortages, or complex sourcing.

• Azacitidine

  Antineoplastic used in selected hematologic malignancies under specialist supervision.
• Carboplatin

  Platinum chemotherapy used in multiple infusion regimens managed by oncology teams.
• Cisplatin

  Platinum-based chemotherapy used in several solid tumor regimens under specialist supervision.
• Fludarabine

  Antineoplastic used in selected hematologic oncology pathways under specialist supervision.
• Fluorouracil (5-FU)

  Antimetabolite used in oncology care, including infusion protocols managed by specialist teams.
• Methotrexate

  Antimetabolite therapy used in oncology and, in other settings, under distinct protocols and monitoring.
• Paclitaxel

  Taxane chemotherapy used in multiple cancer types as part of hospital-managed infusion programs.
• Topotecan

  Topoisomerase inhibitor used in certain oncology regimens according to label and protocol.